Furthermore, blocking Ccl24 in vivo abrogated the exacerbated airway inflammation induced by TPL-2–deficient DCs, demonstrating a previously unappreciated role for DC-intrinsic TPL-2 in regulating Ccl24 to limit severe airway allergy. Here, MAP3K8 is linked to allergic respiratory disease.